Gibson Christopher

Insider

Director

Trades at: RXRX· PACB

30D 90D 1Y

Net shares · 365d

-1.7M

0 buy · 1.7M sell

Net value · 365d

-$8.1M

$0 in · $8.1M out

Sentiment · 365d

Net selling

0% buying · 100% selling

Open-market trades · 365d

0 buy · 1.7M sell

Trading track record · all companies

Running net of open-market buys − sells across every company. Tap the line or a marker for details. ▲ buy · ▼ sell.

Transactions · 365d

Open-market Buys Sells All types

RXRX Exercise·C
Jun 5, 26

Director · 10b5-1

$0

40.0K sh

Own +1%
RXRX Sell·S
Jun 5, 26

Director · 10b5-1

$144.8K

40.0K sh · $3.62

Own -4%
RXRX Exercise·C
Jun 5, 26

Director · 10b5-1

$0

40.0K sh

Own +5%
PACB Grant·A
Jun 3, 26

Director

$0

74.5K sh

Own New
RXRX Exercise·C
May 22, 26

Director · 10b5-1

$0

40.0K sh

Own +1%
RXRX Sell·S
May 22, 26

Director · 10b5-1

$123.2K

40.0K sh · $3.08

Own -4%
RXRX Exercise·C
May 22, 26

Director · 10b5-1

$0

40.0K sh

Own +5%
RXRX Other·F
May 15, 26

Director

$69.4K

22.8K sh · $3.04

Own -3%
RXRX Exercise·C
May 7, 26

Director · 10b5-1

$0

60.0K sh

Own +1%
RXRX Other·G
May 7, 26

Director · 10b5-1

$0

20.0K sh

Own -2%
RXRX Sell·S
May 7, 26

Director · 10b5-1

$134.8K

40.0K sh · $3.37

Own -4%
RXRX Exercise·C
May 7, 26

Director · 10b5-1

$0

60.0K sh

Own +7%
RXRX Exercise·C
Apr 22, 26

Director · 10b5-1

$0

40.0K sh

Own +1%
RXRX Sell·S
Apr 22, 26

Director · 10b5-1

$144.4K

40.0K sh · $3.61

Own -4%
RXRX Exercise·C
Apr 22, 26

Director · 10b5-1

$0

40.0K sh

Own +4%
PACB Grant·A
Apr 8, 26

Director

$0

77.8K sh

Own New
PACB Grant·A
Apr 8, 26

Director

$0

57.5K sh

Own +107%
RXRX Exercise·C
Apr 7, 26

Director · 10b5-1

$0

40.0K sh

Own +1%
RXRX Sell·S
Apr 7, 26

Director · 10b5-1

$124.0K

40.0K sh · $3.10

Own -4%
RXRX Exercise·C
Apr 7, 26

Director · 10b5-1

$0

40.0K sh

Own +4%
RXRX Exercise·C
Mar 23, 26

Director · 10b5-1

$0

40.0K sh

Own +1%
RXRX Exercise·C
Mar 23, 26

Director · 10b5-1

$0

40.0K sh

Own +4%
RXRX Sell·S
Mar 23, 26

Director · 10b5-1

$130.0K

40.0K sh · $3.25

Own -4%
RXRX Exercise·C
Mar 9, 26

Director · 10b5-1

$0

20.0K sh

Own +0%
RXRX Other·G
Mar 9, 26

Director · 10b5-1

$0

20.0K sh

Own -2%
RXRX Exercise·C
Mar 9, 26

Director · 10b5-1

$0

20.0K sh

Own +2%
PACB Grant·A
Mar 3, 26

Director

$0

73.1K sh

Own New
PACB Grant·A
Mar 3, 26

Director

$0

53.9K sh

Own New
RXRX Exercise·C
Feb 19, 26

Director · 10b5-1

$0

40.0K sh

Own +1%
RXRX Exercise·C
Feb 19, 26

Director · 10b5-1

$0

40.0K sh

Own +4%
RXRX Sell·S
Feb 19, 26

Director · 10b5-1

$138.4K

40.0K sh · $3.46

Own -4%
RXRX Other·F
Feb 17, 26

Director · 10b5-1

$95.2K

27.3K sh · $3.49

Own -3%
RXRX Other·F
Feb 6, 26

Director · 10b5-1

$36.9K

10.4K sh · $3.56

Own -1%
RXRX Grant·A
Feb 6, 26

Director · 10b5-1

$0

30.3K sh

Own +3%
RXRX Exercise·C
Feb 4, 26

Director · 10b5-1

$0

40.0K sh

Own +1%
RXRX Exercise·C
Feb 4, 26

Director · 10b5-1

$0

40.0K sh

Own +4%
RXRX Sell·S
Feb 4, 26

Director · 10b5-1

$164.8K

40.0K sh · $4.12

Own -4%
RXRX Exercise·C
Jan 20, 26

Director · 10b5-1

$0

40.0K sh

Own +1%
RXRX Sell·S
Jan 20, 26

Director · 10b5-1

$178.8K

40.0K sh · $4.47

Own -4%
RXRX Exercise·C
Jan 20, 26

Director · 10b5-1

$0

40.0K sh

Own +4%
RXRX Exercise·C
Jan 5, 26

Director · 10b5-1

$0

60.0K sh

Own +1%
RXRX Other·G
Jan 5, 26

Director · 10b5-1

$0

20.0K sh

Own -2%
RXRX Exercise·C
Jan 5, 26

Director · 10b5-1

$0

60.0K sh

Own +7%
RXRX Sell·S
Jan 5, 26

Director · 10b5-1

$170.0K

40.0K sh · $4.25

Own -4%
RXRX Exercise·C
Dec 19, 25

Chief Executive Officer · 10b5-1

$0

40.0K sh

Own +1%
RXRX Exercise·C
Dec 19, 25

Chief Executive Officer · 10b5-1

$0

40.0K sh

Own +4%
RXRX Sell·S
Dec 19, 25

Chief Executive Officer · 10b5-1

$180.0K

40.0K sh · $4.50

Own -4%
RXRX Exercise·C
Dec 4, 25

Chief Executive Officer · 10b5-1

$0

60.0K sh

Own +1%
RXRX Sell·S
Dec 4, 25

Chief Executive Officer · 10b5-1

$185.2K

40.0K sh · $4.63

Own -4%
RXRX Other·G
Dec 4, 25

Chief Executive Officer · 10b5-1

$0

20.0K sh

Own -2%
RXRX Exercise·C
Dec 4, 25

Chief Executive Officer · 10b5-1

$0

60.0K sh

Own +7%
RXRX Exercise·C
Nov 19, 25

Chief Executive Officer · 10b5-1

$0

40.0K sh

Own +1%
RXRX Exercise·C
Nov 19, 25

Chief Executive Officer · 10b5-1

$0

40.0K sh

Own +4%
RXRX Sell·S
Nov 19, 25

Chief Executive Officer · 10b5-1

$166.4K

40.0K sh · $4.16

Own -4%
RXRX Other·F
Nov 17, 25

Chief Executive Officer · 10b5-1

$167.2K

40.4K sh · $4.14

Own -4%
RXRX Exercise·C
Nov 4, 25

Chief Executive Officer · 10b5-1

$0

60.0K sh

Own +1%
RXRX Other·G
Nov 4, 25

Chief Executive Officer · 10b5-1

$0

20.0K sh

Own -2%
RXRX Exercise·C
Nov 4, 25

Chief Executive Officer · 10b5-1

$0

60.0K sh

Own +6%
RXRX Sell·S
Nov 4, 25

Chief Executive Officer · 10b5-1

$208.4K

40.0K sh · $5.21

Own -4%
RXRX Exercise·C
Oct 23, 25

Chief Executive Officer · 10b5-1

$0

100.0K sh

Own +2%
RXRX Sell·S
Oct 23, 25

Chief Executive Officer · 10b5-1

$570.0K

100.0K sh · $5.70

Own -9%
RXRX Exercise·C
Oct 23, 25

Chief Executive Officer · 10b5-1

$0

100.0K sh

Own +10%
RXRX Exercise·C
Oct 10, 25

Chief Executive Officer · 10b5-1

$0

120.0K sh

Own +2%
RXRX Sell·S
Oct 10, 25

Chief Executive Officer · 10b5-1

$604.0K

100.0K sh · $6.04

Own -9%
RXRX Exercise·C
Oct 10, 25

Chief Executive Officer · 10b5-1

$0

120.0K sh

Own +13%
RXRX Other·G
Oct 10, 25

Chief Executive Officer · 10b5-1

$0

20.0K sh

Own -2%
RXRX Exercise·C
Sep 25, 25

Chief Executive Officer · 10b5-1

$0

— sh
RXRX Sell·S
Sep 25, 25

Chief Executive Officer · 10b5-1

$476.0K

100.0K sh · $4.76

Own -9%
RXRX Exercise·C
Sep 25, 25

Chief Executive Officer · 10b5-1

$0

100.0K sh

Own +10%
RXRX Exercise·C
Sep 10, 25

Chief Executive Officer · 10b5-1

$0

120.0K sh

Own +2%
RXRX Sell·S
Sep 10, 25

Chief Executive Officer · 10b5-1

$471.0K

100.0K sh · $4.71

Own -9%
RXRX Other·G
Sep 10, 25

Chief Executive Officer · 10b5-1

$0

20.0K sh

Own -2%
RXRX Exercise·C
Sep 10, 25

Chief Executive Officer · 10b5-1

$0

120.0K sh

Own +13%
RXRX Exercise·C
Aug 26, 25

Chief Executive Officer · 10b5-1

$0

100.0K sh

Own +2%
RXRX Exercise·C
Aug 26, 25

Chief Executive Officer · 10b5-1

$0

100.0K sh

Own +10%
RXRX Sell·S
Aug 26, 25

Chief Executive Officer · 10b5-1

$484.0K

100.0K sh · $4.84

Own -9%
RXRX Other·F
Aug 15, 25

Chief Executive Officer

$227.8K

40.4K sh · $5.64

Own -4%
RXRX Exercise·C
Aug 11, 25

Chief Executive Officer · 10b5-1

$0

541.5K sh · 3 lots

Own +11%
RXRX Exercise·C
Aug 11, 25

Chief Executive Officer · 10b5-1

$0

541.5K sh · 3 lots

Own New
RXRX Sell·S
Aug 11, 25

Chief Executive Officer · 10b5-1

$3.3M

618.2K sh · $5.28 avg · 3 lots

Own -100%
RXRX Other·G
Aug 11, 25

Chief Executive Officer · 10b5-1

$0

10.0K sh

Own -1%

Date▾	Ticker	Role	Type	Shares	Own Δ	Price	Value
Jun 5, 2026	RXRX	Director	Exercise C	40.0K	+1%	—	$0
Jun 5, 2026	RXRX	Director	Sell S	40.0K	-4%	$3.62	$144.8K
Jun 5, 2026	RXRX	Director	Exercise C	40.0K	+5%	—	$0
Jun 3, 2026	PACB	Director	Grant A	74.5K	New	—	$0
May 22, 2026	RXRX	Director	Exercise C	40.0K	+1%	—	$0
May 22, 2026	RXRX	Director	Sell S	40.0K	-4%	$3.08	$123.2K
May 22, 2026	RXRX	Director	Exercise C	40.0K	+5%	—	$0
May 15, 2026	RXRX	Director	Other F	22.8K	-3%	$3.04	$69.4K
May 7, 2026	RXRX	Director	Exercise C	60.0K	+1%	—	$0
May 7, 2026	RXRX	Director	Other G	20.0K	-2%	—	$0
May 7, 2026	RXRX	Director	Sell S	40.0K	-4%	$3.37	$134.8K
May 7, 2026	RXRX	Director	Exercise C	60.0K	+7%	—	$0
Apr 22, 2026	RXRX	Director	Exercise C	40.0K	+1%	—	$0
Apr 22, 2026	RXRX	Director	Sell S	40.0K	-4%	$3.61	$144.4K
Apr 22, 2026	RXRX	Director	Exercise C	40.0K	+4%	—	$0
Apr 8, 2026	PACB	Director	Grant A	77.8K	New	—	$0
Apr 8, 2026	PACB	Director	Grant A	57.5K	+107%	—	$0
Apr 7, 2026	RXRX	Director	Exercise C	40.0K	+1%	—	$0
Apr 7, 2026	RXRX	Director	Sell S	40.0K	-4%	$3.10	$124.0K
Apr 7, 2026	RXRX	Director	Exercise C	40.0K	+4%	—	$0
Mar 23, 2026	RXRX	Director	Exercise C	40.0K	+1%	—	$0
Mar 23, 2026	RXRX	Director	Exercise C	40.0K	+4%	—	$0
Mar 23, 2026	RXRX	Director	Sell S	40.0K	-4%	$3.25	$130.0K
Mar 9, 2026	RXRX	Director	Exercise C	20.0K	+0%	—	$0
Mar 9, 2026	RXRX	Director	Other G	20.0K	-2%	—	$0
Mar 9, 2026	RXRX	Director	Exercise C	20.0K	+2%	—	$0
Mar 3, 2026	PACB	Director	Grant A	73.1K	New	—	$0
Mar 3, 2026	PACB	Director	Grant A	53.9K	New	—	$0
Feb 19, 2026	RXRX	Director	Exercise C	40.0K	+1%	—	$0
Feb 19, 2026	RXRX	Director	Exercise C	40.0K	+4%	—	$0
Feb 19, 2026	RXRX	Director	Sell S	40.0K	-4%	$3.46	$138.4K
Feb 17, 2026	RXRX	Director	Other F	27.3K	-3%	$3.49	$95.2K
Feb 6, 2026	RXRX	Director	Other F	10.4K	-1%	$3.56	$36.9K
Feb 6, 2026	RXRX	Director	Grant A	30.3K	+3%	—	$0
Feb 4, 2026	RXRX	Director	Exercise C	40.0K	+1%	—	$0
Feb 4, 2026	RXRX	Director	Exercise C	40.0K	+4%	—	$0
Feb 4, 2026	RXRX	Director	Sell S	40.0K	-4%	$4.12	$164.8K
Jan 20, 2026	RXRX	Director	Exercise C	40.0K	+1%	—	$0
Jan 20, 2026	RXRX	Director	Sell S	40.0K	-4%	$4.47	$178.8K
Jan 20, 2026	RXRX	Director	Exercise C	40.0K	+4%	—	$0
Jan 5, 2026	RXRX	Director	Exercise C	60.0K	+1%	—	$0
Jan 5, 2026	RXRX	Director	Other G	20.0K	-2%	—	$0
Jan 5, 2026	RXRX	Director	Exercise C	60.0K	+7%	—	$0
Jan 5, 2026	RXRX	Director	Sell S	40.0K	-4%	$4.25	$170.0K
Dec 19, 2025	RXRX	Chief Executive Officer	Exercise C	40.0K	+1%	—	$0
Dec 19, 2025	RXRX	Chief Executive Officer	Exercise C	40.0K	+4%	—	$0
Dec 19, 2025	RXRX	Chief Executive Officer	Sell S	40.0K	-4%	$4.50	$180.0K
Dec 4, 2025	RXRX	Chief Executive Officer	Exercise C	60.0K	+1%	—	$0
Dec 4, 2025	RXRX	Chief Executive Officer	Sell S	40.0K	-4%	$4.63	$185.2K
Dec 4, 2025	RXRX	Chief Executive Officer	Other G	20.0K	-2%	—	$0
Dec 4, 2025	RXRX	Chief Executive Officer	Exercise C	60.0K	+7%	—	$0
Nov 19, 2025	RXRX	Chief Executive Officer	Exercise C	40.0K	+1%	—	$0
Nov 19, 2025	RXRX	Chief Executive Officer	Exercise C	40.0K	+4%	—	$0
Nov 19, 2025	RXRX	Chief Executive Officer	Sell S	40.0K	-4%	$4.16	$166.4K
Nov 17, 2025	RXRX	Chief Executive Officer	Other F	40.4K	-4%	$4.14	$167.2K
Nov 4, 2025	RXRX	Chief Executive Officer	Exercise C	60.0K	+1%	—	$0
Nov 4, 2025	RXRX	Chief Executive Officer	Other G	20.0K	-2%	—	$0
Nov 4, 2025	RXRX	Chief Executive Officer	Exercise C	60.0K	+6%	—	$0
Nov 4, 2025	RXRX	Chief Executive Officer	Sell S	40.0K	-4%	$5.21	$208.4K
Oct 23, 2025	RXRX	Chief Executive Officer	Exercise C	100.0K	+2%	—	$0
Oct 23, 2025	RXRX	Chief Executive Officer	Sell S	100.0K	-9%	$5.70	$570.0K
Oct 23, 2025	RXRX	Chief Executive Officer	Exercise C	100.0K	+10%	—	$0
Oct 10, 2025	RXRX	Chief Executive Officer	Exercise C	120.0K	+2%	—	$0
Oct 10, 2025	RXRX	Chief Executive Officer	Sell S	100.0K	-9%	$6.04	$604.0K
Oct 10, 2025	RXRX	Chief Executive Officer	Exercise C	120.0K	+13%	—	$0
Oct 10, 2025	RXRX	Chief Executive Officer	Other G	20.0K	-2%	—	$0
Sep 25, 2025	RXRX	Chief Executive Officer	Exercise C	—	—	—	$0
Sep 25, 2025	RXRX	Chief Executive Officer	Sell S	100.0K	-9%	$4.76	$476.0K
Sep 25, 2025	RXRX	Chief Executive Officer	Exercise C	100.0K	+10%	—	$0
Sep 10, 2025	RXRX	Chief Executive Officer	Exercise C	120.0K	+2%	—	$0
Sep 10, 2025	RXRX	Chief Executive Officer	Sell S	100.0K	-9%	$4.71	$471.0K
Sep 10, 2025	RXRX	Chief Executive Officer	Other G	20.0K	-2%	—	$0
Sep 10, 2025	RXRX	Chief Executive Officer	Exercise C	120.0K	+13%	—	$0
Aug 26, 2025	RXRX	Chief Executive Officer	Exercise C	100.0K	+2%	—	$0
Aug 26, 2025	RXRX	Chief Executive Officer	Exercise C	100.0K	+10%	—	$0
Aug 26, 2025	RXRX	Chief Executive Officer	Sell S	100.0K	-9%	$4.84	$484.0K
Aug 15, 2025	RXRX	Chief Executive Officer	Other F	40.4K	-4%	$5.64	$227.8K
Aug 11, 2025	RXRX	Chief Executive Officer	Exercise C	541.5K3 lots	+11%	—	$0
Aug 11, 2025	RXRX	Chief Executive Officer	Exercise C	541.5K3 lots	New	—	$0
Aug 11, 2025	RXRX	Chief Executive Officer	Sell S	618.2K3 lots	-100%	$5.28 avg	$3.3M
Aug 11, 2025	RXRX	Chief Executive Officer	Other G	10.0K	-1%	—	$0

Buy Sell Non-market (grant · exercise · gift)

About Gibson Christopher

This profile aggregates every SEC Form 4 insider transaction reported by Gibson Christopher across all companies they trade. Open-market purchases (code P) and sales (code S) are the highest-signal, discretionary trades; grants (A), option exercises (M) and gifts (G) reflect compensation rather than conviction and carry no market price. Figures cover the selected period and update as new filings are ingested.